AdhexPharma’s Post

The rising cost of prescription drugs has become a key driver of overall healthcare spending in the U.S. Last year the U.S. spent $722.5 Billion on overall pharmaceutical expenditures. Recently I had the opportunity to sit down with Jake Frenz, CEO and Founder of SmithRx, to get his thoughts on how pharmacy is impacting employers and their workforce. #employeebenefits #pharmacy #rx #humanresources #benefits #costcontaintment

What approaches can maintain drug affordability without sacrificing innovation in the pharmaceutical industry? Lawmakers are debating strategies to reduce prescription drug costs while maintaining incentives for innovation. The Inflation Reduction Act aims to make drugs more affordable but has led to decreased investment in some areas. Discussions emphasize the need for reforms in pharmacy benefit management and sustainable budgeting to continue fostering innovation. At Lyfegen, we understand the complexity of balancing affordability with innovation. Our value-based solutions enable pharmaceutical companies to accelerate drug access through streamlined negotiations and data-driven insights, all without compromising innovation. Learn more on lyfegen.com/pharma #HealthTech #Pharma #DrugPricing #Innovation #InflationReductionAct

Exploring the latest trends in the generic pharmaceuticals market, including market growth, key players, and future projections. Stay informed about the economic aspects driving the industry forward. #MarketTrends #GenericPharmaceuticals #IndustryGrowth

Have you seen the latest edition of Pharmaceutical & Cosmetic Review? We explored several captivating themes in April, ranging from sustainable ingredients for home care products to ground-breaking advancements in pharmaceutical manufacturing. Want to read more about these and other content we featured? Click here: https://lnkd.in/ds2MR8Jz   #cleanhomecare #sustainableingredients #pharmamanufacturing #packagingtechnology #beautypackaging #productionequipment #pharmaprocessing #haircare #curlyhaircare #veganingredients #cleanbeauty #skincareinnovation

📈 80% of Wholesalers Are Already Gaining Significant Benefits from Dydrogesterone! 💊 Are you ready to elevate your business? 🌟 Dydrogesterone has become a game-changer in the pharmaceutical industry, with wholesalers reporting impressive growth. Here's why it's in high demand: ✅ Proven effectiveness in hormone therapy ✅ Strong market demand boosting sales ✅ Trusted by healthcare professionals Don't miss out on this opportunity to enhance your product portfolio. 🚀 📞 Contact us today at +91-8556088677 to learn how Dydrogesterone can benefit your business. #DydrogesteroneSuccess #PharmaWholesale #B2BPharma #HealthcareInnovation #PharmaceuticalGrowth

"The [Teva Pharmaceuticals] stock surged 13%. The reason: strong results of its once-monthly injectable for schizophrenia." Teva's investigational extended-release olanzapine and the already-approved UZEDY are both powered by MedinCell's Long-Acting Injectable technology. We are proud that our innovative technology is at the core of two major assets in Teva's "Pivot to Growth" strategy. This strong partnership underscores our commitment to advancing healthcare through cutting-edge solutions. Read more in The Wall Street Journal: https://lnkd.in/en8bFgxZ #Pharmaceuticals #Innovation #Healthcare #MedinCell #TevaPharmaceuticals

Tarun Kumar from Novartis says ‘The Omni Advantage' is a must read! How amazing is that. 😊 “The Omni Advantage presents a compelling framework tailored specifically for the pharmaceutical industry, offering a strategic roadmap to navigate the complexities of multichannel engagement in healthcare. Through meticulous research and real-world case studies, the book illustrates how pharmaceutical companies can leverage omnichannel strategies to enhance patient care, optimise sales and marketing efforts, and foster stronger stakeholder relationships. A must-read for pharmaceutical executives and professionals seeking to harness the full potential for omnichannel engagement in today's evolving healthcare landscape." Thank you, Tarun! Get your copy 👇 📙https://lnkd.in/ePcDEW56 #TheOmniAdvantage #Pharma #Pharmaceuticals

Exciting developments are on the horizon in the pharmaceutical industry as India's copycat drugmakers prepare to introduce more affordable weight-loss drugs. This blog post explores how these companies are positioning themselves to meet growing demand for budget-friendly healthcare solutions in a market that increasingly values accessibility. The implications for consumers and the broader health sector are significant, making this a must-read for anyone interested in healthcare innovation and market trends. Discover the full insights by reading the blog post here: [FT.com](https://ift.tt/Rhpdvft).

Traditionally, pharmaceutical companies have maintained an arm's-length relationship with consumers, navigating through physicians, pharmacists, and insurers. But the landscape is shifting. With the advent of pharma telehealth platforms like Eli Lilly's LillyDirect and Pfizer's forthcoming service, drug companies are now connecting directly with consumers like never before. Read the article by Elisabeth Svensson to learn more about how telehealth is changing the relationship with consumers. https://lnkd.in/e5vG-GmM #Pharma #Telehealth #PharmaTelehealth #PatientEngagement #HealthcareInnovation

Quiz for those involved in pharmacy benefits! Imagine you're an executive at a discount-based PBM (which is all traditional PBMs) and you're preparing for a negotiation with a pharmaceutical company about the cost of a new drug for your members. Which of these three options pictured would you optimize for in your negotiation: A, B, or C? And why? The answer helps explain why drug prices keep going up... (If you need a hint, the explanation is in Alan Pannier, Pharm D,MBA's blog post: https://lnkd.in/gc-wA_GM)